Navigation Links
Atrium Medical Receives FDA Approval for its Novel C-QUR Lite(TM) V-Patch and C-QUR Edge(TM) V-Patch
Date:5/8/2008

HUDSON, N.H., May 8 /PRNewswire/ -- Atrium Medical Corporation is pleased to announce it has obtained US FDA 510(K) approval for two new Omega 3 surgical mesh products; C-QUR Edge(TM) V-Patch and C-QUR Lite(TM) V-Patch.

These new products are indicated for use in the surgical repair and reinforcement of soft tissue, including hernia repair -- a common procedure performed more than 700,000 times in the US each year. This novel technology combines Atrium's ProLite Ultra(TM) polypropylene surgical mesh with a proprietary, pharmaceutical grade Omega 3 fatty acid bio-absorbable gel coating. Atrium's discovery of combining an inert thin wall polypropylene mesh with an Omega 3 biological coating in pre-clinical studies has demonstrated a minimization of tissue attachment as well as a significant reduction in both foreign body reaction and inflammation, resulting in a well healed, reinforced repair.

C-QUR Edge(TM) V-Patch and C-QUR Lite(TM) V-Patch are designed to simplify umbilical, epigastric, trocar-site, and other small abdominal wall hernia repairs. C-QUR Edge(TM) V-Patch offers long-term protection from visceral tissue attachment when placed intra-abdominally while the C-QUR Lite(TM) version offers superior handling and healing characteristics for a pre-peritoneal repair.

The use of Atrium's all natural Omega 3 bio-absorbable coating with its advanced lightweight surgical mesh provides today's clinicians with a broad spectrum of options for soft tissue repair. Atrium's C-QUR Edge(TM) V-Patch and C-QUR Lite(TM) V-Patch will be available in a variety of sizes mid-year 2008.

About Atrium

Atrium's vast expertise in medical device technologies for the treatment of cardiovascular disease, hernia and adhesion prevention has brought a number of breakthrough advances in several diversified healthcare markets including interventional cardiology and radiology, chest trauma care and thoracic drainage, vascular surgery, and soft tissue rep
'/>"/>

SOURCE Atrium Medical Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Atrium Innovations Announces Management Changes
2. Atrium Innovations to Hold 2007 Third Quarter Financial Results Conference Call and Webcast on November 8
3. Atrium Announces a Significant Increase in Revenues and Earnings for the Third Quarter of 2007
4. Atrium Innovations to Hold 2007 Fourth Quarter and Full-Year Financial Results Conference Call and Webcast on February 29
5. Atrium Innovations to Hold 2008 First Quarter Financial Results Conference Call and Webcast on May 6
6. Atrium shows a strong financial performance for its first quarter
7. AEterna Zentaris completes management team with the appointment of Chief Medical Officer
8. VisEn Medical Files Action to Invalidate New Caliper Life Sciences Patent
9. China Medical Technologies to Participate in the Morgan Stanleys 2007 China Medical Corporate Day
10. Pathway Medical Technologies Adds Joe Rafferty as VP, Sales, and Moves To Larger Facility to Accommodate Rapid Growth
11. BioMS Medical announces its intention to renew a normal course issuer bid

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/5/2009)..., PARSIPPANY, N.J., Nov. 5 DSM Pha...ade a manufacturing alliance with Galenix, Saint J...ed commercial scale manufacturing partner for Gale...SM and Galenix will collaborate on business develo...very technologies, based on the strength of Galeni...
(Date:11/5/2009)..., LYNBROOK, N.Y., Nov. 5 ... a biopharmaceutical company developing first-in-c...ts financial results for the third quarter ended S... that, in September of this year, the FDA,s Arthri... a vote of 12-0, the approval of XIAFLEX(TM) for t...
(Date:11/5/2009)..., AUSTIN, Texas, Nov. 5 SpineSmith...Osteo, Inc. to co-develop a unique scaffold that m...ollowing evaluation of several commercial products...nt, the company believes the GenOsteo scaffold rep...at creates a unique and ideal environment for the ...
(Date:11/4/2009)... This webinar, which will be ...one working in continuous flow chemistry processin...low cell inline using various meso and micro scale...f over 670 publications has been recognized with s...st recently the 2009 Tetrahedron Prize. , ...
Breaking Biology Technology:DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 2DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 3BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 2BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 3BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 4BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 5SpineSmith Partners and GenOsteo Announce Collaborative Product Development Agreement 2Professor Steven Ley of University of Cambridge will Present Free Webinar, 'Application of the ReactIR Flow Cell to Continuous Processing Technology' 2Professor Steven Ley of University of Cambridge will Present Free Webinar, 'Application of the ReactIR Flow Cell to Continuous Processing Technology' 3
...elixis,Inc. (Nasdaq: EXEL ) announced earlier tod...ommitment from Deerfield Management. The arrangeme...ive conference call at 5:00 a.m.,PT/8:00 a.m. ET t...the,discussion, visit the Event Calendar page unde...ay of the conference call will be available until ...
...ne Control, Trait Stacking in ...MOND, Calif., June 5 Dow,AgroSciences LLC and San...today the successful completion of research milest...l License Agreement. These milestones represent,th...DNA-binding protein,(ZFP) technology to the genera...
...C Santa Barbara,s Solid-State Lighting and Energy ...nce of Asturias Award for Technical and Scientific... is presented with a medal and a Joan Miro sculptu...ecipients in each category also share a 50,000 (US...esearch prize is given annually to "the individual...
Other Biology Technology:Dow AgroSciences, Sangamo BioSciences Announce the Achievement of Key Milestones in Plant Agriculture Collaboration 2Dow AgroSciences, Sangamo BioSciences Announce the Achievement of Key Milestones in Plant Agriculture Collaboration 3Dow AgroSciences, Sangamo BioSciences Announce the Achievement of Key Milestones in Plant Agriculture Collaboration 4Dow AgroSciences, Sangamo BioSciences Announce the Achievement of Key Milestones in Plant Agriculture Collaboration 5
(Date:11/4/2009)...ewswire-FirstCall/ -- Quest Diagnostics Incorporat...diagnostic testing, information and services, anno...0, 2009, income from continuing operations rose to...60 million, or $0.81 per diluted share, for the th...s were reduced by a $0.03 per share charge associa...
(Date:11/4/2009)...PRNewswire/ -- GenVault Corporation, the leader in...mic discovery, medicine and identification, today ...sident and CEO, will be presenting at the BIOCOM I...d 27th in La Jolla, CA. ,, During the presentat...mpany together with recent customer, technical and...
(Date:11/4/2009)...RNewswire/ -- GenVault Corporation (Carlsbad, CA) ...as joined its Board of Directors. Dr. Brody, the ...ute, is an acclaimed physician-scientist and unive..., Dr. Brody served as president of The Johns Hopki...demy of Engineering and the Institute of Medicine,...
Breaking Biology News(10 mins):Quest Diagnostics Reports Strong Performance in Third Quarter 2009 2Quest Diagnostics Reports Strong Performance in Third Quarter 2009 3Quest Diagnostics Reports Strong Performance in Third Quarter 2009 4Quest Diagnostics Reports Strong Performance in Third Quarter 2009 5Quest Diagnostics Reports Strong Performance in Third Quarter 2009 6Quest Diagnostics Reports Strong Performance in Third Quarter 2009 7Quest Diagnostics Reports Strong Performance in Third Quarter 2009 8Quest Diagnostics Reports Strong Performance in Third Quarter 2009 9Quest Diagnostics Reports Strong Performance in Third Quarter 2009 10Quest Diagnostics Reports Strong Performance in Third Quarter 2009 11Quest Diagnostics Reports Strong Performance in Third Quarter 2009 12Quest Diagnostics Reports Strong Performance in Third Quarter 2009 13Quest Diagnostics Reports Strong Performance in Third Quarter 2009 14Quest Diagnostics Reports Strong Performance in Third Quarter 2009 15Quest Diagnostics Reports Strong Performance in Third Quarter 2009 16Quest Diagnostics Reports Strong Performance in Third Quarter 2009 17GenVault Corporation to Present at the 2009 BIOCOM Investor Conference 2Dr. William Brody, President of the Salk Institute for Biological Studies, Appointed to GenVault's Board of Directors 2Dr. William Brody, President of the Salk Institute for Biological Studies, Appointed to GenVault's Board of Directors 3SYGNIS to Present at the 11th Rodman 26 Renshaw Annual Global Investment Conference 56338 1SYGNIS to Present at the 11th Rodman 26 Renshaw Annual Global Investment Conference 56338 2REGURIN 28R 29 XL 28trospium chloride 29 Once Daily Tablets Now Available in the UK for the Treatment of Overactive Bladder 56335 1REGURIN 28R 29 XL 28trospium chloride 29 Once Daily Tablets Now Available in the UK for the Treatment of Overactive Bladder 56335 2REGURIN 28R 29 XL 28trospium chloride 29 Once Daily Tablets Now Available in the UK for the Treatment of Overactive Bladder 56335 3REGURIN 28R 29 XL 28trospium chloride 29 Once Daily Tablets Now Available in the UK for the Treatment of Overactive Bladder 56335 4REGURIN 28R 29 XL 28trospium chloride 29 Once Daily Tablets Now Available in the UK for the Treatment of Overactive Bladder 56335 5Founder of Curidium Launches Elixior an Advisory Company Focused on the Development and Growth of Innovative Personalized Medicine Businesses 56332 1Founder of Curidium Launches Elixior an Advisory Company Focused on the Development and Growth of Innovative Personalized Medicine Businesses 56332 2
...y (ASH TM ) and American Board of Internal Medicin...a new wave of performance evaluation tools for blo...uirements to maintain ABIM certification, ASH and ...rovement Module (PIM), a web-based tool physicians...ment requirement for recertification. Participants...
...is the deadliest form of the disease, with fewer t...ear prognosis for survival. To find out what drive...d to rapidly screen for drugs that might stop IBC... Diego (UCSD), have come up with an unlikely yet ...ble for xenografts. , More properly, it’s a trans...
...s are heading a worldwide research project which c...diarrhoea in children in developing countries. , T... being piloted in four hospitals in India, will of...ms of the disease quickly, cheaply and with little...ications for improving children,s health could be ...
Other Biology News:New tool helps blood specialists improve patient care 2A fisheye view of the deadliest breast cancer 2Hope for major advance in fighting world killer disease 2Hope for major advance in fighting world killer disease 3
Mouse Anti-Catenin, beta, N-terminal (exon 2) Monoclonal Antibody, Unconjugated, Clone BDI710 from Meridian Life Science, Inc.
Anti-CaMKII (Calmodulin-dependent Protein Kinase II) Monoclonal Antibody, Unconjugated, Clone 6G9 (2) from CHEMICON
Rabbit Anti-SLAP-2 Polyclonal Antibody, Unconjugated from Calbiochem
...s ligand immobilization can be coupled with a liga...or to create an affinity matrix of choice. Affi-Ge...rimary amines. Affi-Gel 10 gel couples neutral or ... gel couples acidic proteins with pI less than 6.5...
Biology Products: